Highest development stage: Preclinical

Development status: Inactive

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: Sphingomyelin phosphodiesterase inhibitors; low activity against bacteriodes and other anaerobes

Reason dropped: Very low potency to tested bacteria